Overview

Sulfasalazine in Patients With Metastatic Colorectal Cancer

Status:
Recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the potential efficacy and safety of sulfasalazine in patients with metastatic colorectal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Sulfasalazine